Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b ...
Barchart on MSN

3 option ideas to consider this Wednesday for income and growth

Today, we are using some moving average filters to find bullish stocks and then looking at a couple of different trade ideas. First the stock scanner: Which produces these results: Now that we have ...